| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9313133 | Urology | 2005 | 4 Pages |
Abstract
The BTA stat, survivin assay, and urine cytology were unable to predict bladder cancer cases in our cohort of patients with SCI. Cystoscopy, therefore, remains the gold standard for bladder cancer surveillance in patients with SCI.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Benjamin Davies, Joseph J. Chen, Timothy McMurry, Douglas Landsittel, Nancy Lewis, Gilbert Brenes, Robert H. Getzenberg,